AMP-activated protein kinase, a metabolic master switch: Possible roles in Type 2 diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 1 40-1, 1999, Pages

  Winder, W W ^a   Hardie, D G ^b  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adenosine 5' monophosphate activated protein kinase kinase; Fatty acid oxidation; Glucose uptake; GLUT 4; Insulin insensitivity; Malonylcoenzyme A

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; INSULIN; MALONYL COENZYME A; TRIACYLGLYCEROL;

CHOLESTEROL SYNTHESIS; ENZYME ACTIVITY; FATTY ACID OXIDATION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 0032792665     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.1.e1     Document Type: Review

References (91)

1. Akkan, A. G., and W. J. Malaisse. Insulinotropic action of AICA riboside. I. Insulin release by isolated islets and the perfused pancreas. Diabetes Res. 25: 13-23, 1994.
2. Alam, N., and E. D. Saggerson. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle. Biochem. J. 334: 233-241, 1998.
3. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 21: S40-S44, 1998.
4. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 21: S5-S19, 1998.
5. Antinozzi, P. A., L. Segall, M. Prentki, J. D. McGarry, and C. B. Newgard. Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. J. Biol. Chem. 273: 16146-16154, 1998.
6. Bergeron, R., R. R. Russell III, L. H. Young, J.-M. Ren, M. Marcucci, A. Lee, and G. I. Shulman. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am. J. Physiol. 276 (Endocrinol. Metab. 39): E938-E944, 1999.
7. Beri, R. K., A. E. Marley, C. G. See, W. F. Sopwith, K. Aguan, D. Carling, and F. Carey. Molecular cloning, expression and chromosomal localisation of human AMP-activated protein kinase. FEBS Lett. 356: 117-121, 1994.
8. Bonen, A., M. G. Clark, and E. J. Henriksen. Experimental approaches in muscle metabolism: hindlimb perfusion and isolated muscle incubations. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E1-E16, 1994.
9. Carling, D., P. R. Clarke, V. A. Zammit, and D. G. Hardie. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur. J. Biochem. 186: 129-136, 1989.
10. Carlson, C. L., and W. W. Winder. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and following exercise. J. Appl. Physiol. 86: 669-674, 1999.
11. Ching, Y. P., S. P. Davies, and D. G. Hardie. Analysis of the specificity of the AMP-activated protein kinase by site-directed mutagenesis of bacterially expressed 3-hydroxy 3-methylglutaryl-CoA reductase, using a single primer variant of the unique site elimination (USE) method. Eur. J. Biochem. 237: 800-808, 1996.
12. Corkey, B. E., M. C. Glennon, K. S. Chen, J. T. Deeney, F. M. Matschinsky, and M. Prentki. A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta cells. J. Biol. Chem. 264: 21608-21612, 1989.
13. Corton, J. M., J. G. Gillespie, and D. G. Hardie. Role of the AMP-activated protein kinase in the cellular stress response. Current Biol. 4: 315-324, 1994.
14. Corton, J. M., J. G. Gillespie, S. A. Hawley, and D. G. Hardie. 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 229: 558-565, 1995.
15. Dale, S., W. A. Wilson, A. M. Edelman, and D. G. Hardie. Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I. FEBS Lett. 361: 191-195, 1995.
16. Davies, S. P., D. Carling, M. R. Munday, and D. G. Hardie. Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets. Eur. J. Biochem. 203: 615-623, 1992.
17. Davies, S. P., N. R. Helps, P. T. W. Cohen, and D. G. Hardie. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Cα and native bovine protein phosphatase-2AC. FEES Lett. 377: 421-425, 1995.
18. Devlin, J. T., M. Hirshman, E. D. Horton, and E. S. Horton. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after a single bout of exercise. Diabetes 36: 434-439, 1987.
19. Dobbins, R. L., M. W. Chester, M. B. Daniels, J. D. McGarry, and D. T. Stein. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47: 1613-1618, 1998.
20. Dyck, J. R. B., G. Gao, J. Widmer, D. Stapleton, C. S. Fernandez, B. E. Kemp, and L. A. Witters. Regulation of the 5′-activated protein kinase activity by the non-catalytic and γ subunits. J. Biol. Chem. 271: 17798-17803, 1996.
21. Easom, R. A., and V. A. Zammit. Diurnal changes in the fraction of 3-hydroxy-3-methylglutaryl-CoA reductase in the active form in rat liver microsomal fractions. Biochem. J. 220: 739-745, 1984.
22. Easom, R. A., and V. A. Zammit. Acute effects of starvation and treatment of rats with anti-insulin serum, glucagon and catecholamines on the state of phosphorylation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase in vivo. Biochem. J. 241: 183-188, 1987.
23. Eriksson, J., S. Taimela, and V. A. Koivisto. Exercise and the metabolic syndrome. Diabetologia 40: 125-135, 1997.
24. Etgen, G. J., Jr., J. Jensen, C. M. Wilson, D. G. Hunt, S. W. Cushman, and J. L. Ivy. Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E864-E869, 1997.
25. Ferrannini, E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev. 19: 477-490, 1998.
26. Foretz, M., D. Carling, C. Guichard, P. Ferr, and F. Foufelle. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J. Biol. Chem. 273: 14767-14771, 1998.
27. Gerich, J. E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 19: 491-503, 1998.
28. Goodyear, L. J., and B. B. Kahn. Exercise, glucose transport, and insulin sensitivity. Annu. Rev. Med. 49: 235-261, 1998.
29. Han, D.-H., P. A. Hansen, L. A. Nolte, and J. O. Holloszy. Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47: 1671-1675, 1998.
30. Hardie, D. G., and D. Carling. The AMP-activated protein kinase. Fuel gauge of the mammalian cell? Eur. J. Biochem. 246: 259-273, 1997.
31. Hardie, D. G., D. Carling, and M. Carlson. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Ann. Rev. Biochem. 67: 821-855, 1998.
32. Hawley, S. A., M. Davison, A. Woods, S. P. Davies, R. K. Beri, D. Carling, and D. G. Hardie. Characterization of the AMP-activated protein kinase kinase from rat liver, and identification of threonine-172 as the major site at which it phosphorylates and activates AMP-activated protein kinase. J. Biol. Chem. 271: 27879-27887, 1996.
33. 2+/calmodulin the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 270: 27186-27191, 1995.
34. Hayashi, T., M. F. Hirshman, E. J. Kurth, W. W. Winder, and L. J. Goodyear. Evidence for 5′-AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
35. Hayashi, T., J. F. P. Wojtaszewski, and L. J. Goodyear. Exercise regulation of glucose transport in skeletal muscle. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E1039-E1051, 1997.
36. Henin, N., M. F. Vincent, H. E. Gruber, and G. Van den Berghe. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 9: 541-546, 1995.
37. Henin, N., M. F. Vincent, and G. Van den Berghe. Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim. Biophys. Acta 1290: 197-203, 1996.
38. Holloszy, J. O., and P. A. Hansen. Regulation of glucose transport into skeletal muscle. Rev. Physiol. Biochem. Pharmacol. 128: 99-193, 1996.
39. Holloszy, J. O., and W. M. Kohrt. Regulation of carbohydrate and fat metabolism during and after exercise. Annu. Rev. Nutr. 16: 121-138, 1996.
40. Holloszy, J. O., J. Schultz, J. Kusnierkiewicz, J. M. Hagberg, and A. A. Ehsani. Effects of exercise on glucose tolerance and insulin resistance. Acta Med. Scand., Suppl. 711: 55-65, 1986.
41. Houmard, J. A., P. C. Egan, P. D. Neufer, J. E. Friedman, W. S. Wheeler, R. G. Israel, and G. L. Dohm. Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E437-E443, 1991.
42. Hutber, C. A., D. G. Bardie, and W. W. Winder. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E262-E266, 1997.
43. Ivy, J. L. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med. 24: 321-336, 1997.
44. Kudo, N., A. J. Barr, R. L. Barr, S. Desai, and G. D. Lopaschuk. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270: 17513-17520, 1995.
45. Leclerc, I., A. Kahn, and B. Doiron. The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett. 431: 180-184, 1998.
46. Liang, Y., and F. M. Matschinsky. Content of CoA-esters in perifused rat islets stimulated by glucose and other fuels. Diabetes 40: 327-333, 1991.
47. Louis, N. A., and L. A. Witters. Glucose regulation of acetyl-CoA carboxylase in hepatoma and islet cells. J. Biol. Chem. 267: 2287-2293, 1992.
48. Malaisse, W. J., I. Conget, A. Sener, and P. Rorsman. Insulinotropic action of AICA riboside. II. Secretory, metabolic and cationic aspects. Diabetes Res. 25: 25-37, 1994.
49. Martin, I. K., A. Katz, and J. Wahren. Splanchnic and muscle metabolism during exercise in NIDDM patients. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E583-E590, 1995.
50. McGarry, J. D. Glucose-fatty acid interactions in health and disease. Am. J. Clin. Nutr. 67, Suppl. 3: 500S-504S, 1998.
51. McGarry, J. D., and N. F. Brown. The mitochondrial carnitine palmitoyltransferase system from concept to molecular analysis. Eur. J. Biochem. 244: 1-14, 1997.
52. Merrill, G. F., E. J. Kurth, D. G. Hardie, and W. W. Winder. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E1107-E1112, 1997.
53. Merrill, G. F., E. J. Kurth, B. B. Rasmussen, and W. W. Winder. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle. J. Appl. Physiol. 85: 1909-1914, 1998.
54. Muoio, D. M., K. Seefeld, L. A. Witters, and R. A. Coleman. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem. J. 338: 783-791, 1999.
55. Oakes, N. D., K. S. Bell, S. M. Furler, S. Camilleri, A. K. Saha, N. B. Ruderman, D. J. Chisholm, and E. W. Kraegen. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise. Diabetes 46: 2022-2028, 1997.
56. Ponticos, M., Q. L. Lu, J. E. Morgan, D. G. Hardie, T. A. Partridge, and D. Carling. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 17: 1688-1699, 1998.
57. Prentki, M., and B. E. Corkey. Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45: 273-283, 1996.
58. 1 mice. Arterioscler. Thromb. Vasc. Biol. 17: 3286-3293, 1997.
59. Rasmussen, B. B., C. R. Hancock, and W. W. Winder. Postexercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase. J. Appl. Physiol. 85: 1629-1634, 1998.
60. Rasmussen, B. B., and W. W. Winder. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J. Appl. Physiol. 83: 1104-1109, 1997.
61. Ren, J. M., C. F. Semenkovich, E. A. Gulve, J. Gao, and J. O. Holloszy. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J. Biol. Chem. 269: 14396-14401, 1994.
62. Ruderman, N., D. Chisholm, X. Pi-Sunyer, and S. Schneider. The metabolically obese, normal weight individual revisited. Diabetes 47: 699-713, 1998.
63. Ruderman, N. B., A. K. Saha, D. Vavvas, S. J. Heydrick, and T. G. Kurowski. Lipid abnormalities in muscle of insulin-resistant rodents - the malonyl-CoA hypothesis. Ann. NY Acad. Sci. 827: 221-230, 1997.
64. Ruderman, N. B., A. K. Saha, D. Vavvas, T. Kurowski, D. R. Laybutt, C. Schmitz-Peiffer, T. Biden, and E. W. Kraegen. Malonyl-CoA as a metabolic switch and regulator of insulin sensitivity. Adv. Exp. Med. Biol. 441: 263-270, 1998.
65. Ruderman, N. B., A. K. Saha, D. Vawas, and L. A. Witters. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 276 (Endocrinol. Metab. 39): E1-E18, 1999.
66. Saha, A. K., D. Vavvas, T. G. Kurowski, A. Apazidis, L. A. Witters, E. Shafrir, and N. B. Ruderman. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E641-E648, 1997.
67. Sabina, R. L., D. Patterson, and E. W. Holmes. 5-Amino-4-imidazole carboxamide riboside (Z-riboside) metabolism in eukaryotic cells. J. Biol. Chem. 260: 6107-6114, 1991.
68. Salt, I. P., J. W. Celler, S. A. Hawley, A. Prescott, A. Woods, D. Carling, and D. G. Hardie. AMP-activated protein kinase -greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform. Biochem. J. 334: 177-187, 1998.
69. Salt, I. P., G. Johnson, S. J. H. Ashcroft, and D. G. Hardie. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic β cells, and may regulate insulin release. Biochem. J. 335: 533-539, 1998.
70. Schmitz-Peiffer, C., C. L. Browne, N. D. Oakes, A. Watkinson, D. J. Chisholm, E. W. Kraegen, and T. J. Biden. Alterations in the expression and cellular localization of protein kinase C isozymes ∈ and θ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169-178, 1997.
71. Stapleton, D., K. I. Mitchelhill, G. Gao, J. Widmer, B. J. Mitchell, T. Teh, C. M. House, C. S. Fernandez, T. Cox, L. A. Witters, and B. E. Kemp. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271: 611-614, 1996.
72. Stapleton, D., E. Woollatt, K. I. Mitchelhill, J. K. Nicholl, C. S. Fernandez, B. J. Michell, L. A. Witters, D. A. Power, G. R. Sutherland, and B. E. Kemp. AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett. 409: 452-456, 1997.
73. Sullivan, J. E., K. J. Brocklehurst, A. E. Marley, F. Carey, D. Carling, and R. K. Beri. Inhibition of lipolysis and lipogenesis in isolated rat hepatocytes with AICAR, a cell permeable activator of AMP-activated protein kinase. FEBS Lett. 353: 33-36, 1994.
74. Thornton, C., M. A. Snowden, and D. Carling. Identification of a novel AMP-activated protein kinase subunit isoform that is highly expressed in skeletal muscle. J. Biol. Chem. 273: 12443-12450, 1998.
75. Trovati, M., Q. Carta, F. Cavalot, S. Vitali, C. Banaudi, P. G. Lucchina, F. Fiocchi, and G. Lenti. Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 7: 416-420, 1984.
76. Trumble, G. E., M. A. Smith, and W. W. Winder. Purification and characterization of rat skeletal muscle acetyl-CoA carboxylase. Eur. J. Biochem. 231: 192-198, 1995.
77. US Department of Health and Human Services. The effects of physical activity on health and disease. In: Physical Activity and Health: A Report of the Surgeon General. Washington, DC: Centers for Disease Prevention and Control, 1996.
78. Vavvas, D., A. Apazidis, A. K. Saha, J. Gamble, A. Patel, B. E. Kemp, L. A. Witters, and N. B. Ruderman. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 272: 13256-13261, 1997.
79. Velasco, G., M. J. H. Geelen, and M. Guzman. Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch. Biochem. Biophys. 337: 169-175, 1997.
80. Vincent, M. F., P. Marangos, H. E. Gruber, and G. Van den Berghe. AICA riboside inhibits gluconeogenesis in isolated rat hepatocytes. Adv. Exp. Med. Biol. 309B: 1991-1995, 1991.
81. Wallberg-Henriksson, H., J. Rincon, and J. R. Zierath. Exercise in the management of non-insulin-dependent diabetes mellitus. Sports Med. 25: 25-35, 1998.
82. Winder, W. How to make muscle use fat - coupling of muscle contraction with increased fatty acid oxidation. The Biochemist 20: 24-27, 1998.
83. Winder, W. W. Intramuscular mechanisms regulating fatty acid oxidation during exercise. Adv. Exp. Med. Biol. 441: 239-248, 1998.
84. Winder, W. W. Malonyl-CoA - regulator of fatty acid oxidation in muscle during exercise. Exercise Sport Sci. Rev. 26: 117-132, 1998.
85. Winder, W. W., J. Arogyasami, I. M. Elayan, and D. Cartmill. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E266-E271, 1990.
86. Winder, W. W., and D. G. Hardie. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E299-E304, 1996.
87. Winder, W. W., H. A. Wilson, D. G. Hardie, B. B. Rasmussen, C. A. Hutber, G. B. Call, R. D. Clayton, L. M. Conley, S. Yoon, and B. Zhou. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J. Appl. Physiol. 82: 219-225, 1997.
88. Woods, A., I. Salt, J. Scott, D. G. Hardie, and D. Carling. The α1 and α2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397: 347-351, 1996.
89. Yeh, J. I., E. A. Gulve, L. Remeh, and M. J. Birnbaum. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J. Biol. Chem. 270: 2107-2111, 1995.
90. Young, M. E., G. K. Radda, and B. Leighton. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR - an activator of AMP-activated protein kinase. FEBS Lett. 382: 43-47, 1996.
91. Zhang, S., and K. H. Kim. Essential role of acetyl-CoA carboxylase in the glucose-induced insulin secretion in a pancreatic beta-cell line. Cell Signal. 10: 35-42, 1998.